Neuroone Medical Technologies is trading 6.9% up at $2.17, with no clear company-specific catalyst confirmed.
- Latest reported results showed 16% year-over-year revenue growth, alongside a net loss and cash concerns.
- Released August 13, the results do not clearly explain today’s gain; broader markets are mixed, and no clear company-specific announcement dated August 24, 2026, was identified in available coverage.